UK markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
154.34+3.12 (+2.06%)
As of 02:59PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts21212222
Avg. Estimate-1.11-1.06-3.63-1.84
Low estimate-1.57-1.69-5.56-4.38
High estimate-0.36-0.31-1.072.31
Year ago EPS-2.211.15-3.52-3.63
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts23222827
Avg. Estimate444.96M459.42M1.87B2.29B
Low estimate415M441M1.73B1.48B
High estimate489M495.5M2B2.97B
Year ago sales318.75M750.53M1.83B1.87B
Sales growth (year/est)39.60%-38.80%2.00%23.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.37-1.34-1.32-1.18
Actual EPS-2.211.15-1.1-0.52
Difference-0.842.490.220.66
Surprise %-61.30%185.80%16.70%55.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.11-1.06-3.63-1.84
7 days ago-1.04-1.1-4.11-1.76
30 days ago-1.04-1.1-4.18-1.76
60 days ago-1.03-1.1-4.18-1.77
90 days ago-1.21-1.32-4.2-1.04
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days65114
Up last 30 days10112210
Down last 7 daysN/AN/AN/AN/A
Down last 30 days7838
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.49.80%N/AN/AN/A
Next qtr.-192.20%N/AN/AN/A
Current year-3.10%N/AN/AN/A
Next year49.30%N/AN/AN/A
Next 5 years (per annum)-177.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A